Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion.
作者信息
Doshi Mona D, Gordon Elisa J, Freedman Barry I, Glover Craig, Locke Jayme E, Thomas Christie P
机构信息
Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MI.
Department of Surgery-Transplantation, Northwestern University, Chicago, IL.
出版信息
Transplantation. 2021 Oct 1;105(10):2132-2134. doi: 10.1097/TP.0000000000003641.
Abstract
摘要
相似文献
1
Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion.将APOL1肾脏风险变异检测纳入活体肾供体评估：专家小组意见
Transplantation. 2021 Oct 1;105(10):2132-2134. doi: 10.1097/TP.0000000000003641.
2
Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.活体肾捐献者评估中 APOL1 基因分型的实用考虑。
Transplantation. 2020 Jan;104(1):27-32. doi: 10.1097/TP.0000000000002933.
3
Genotype and Renal Function of Black Living Donors.黑人活体供者的基因型与肾功能。
J Am Soc Nephrol. 2018 Apr;29(4):1309-1316. doi: 10.1681/ASN.2017060658. Epub 2018 Jan 16.
4
APOL1 Genetic Testing in Living Kidney Transplant Donors.APOL1 基因检测在活体肾移植供者中的应用。
Am J Kidney Dis. 2019 Oct;74(4):538-543. doi: 10.1053/j.ajkd.2019.02.007. Epub 2019 Apr 11.
5
Genetic Testing for Genetic Variants in Clinical Practice: Finally Starting to Arrive.临床实践中基因变异的基因检测：终于开始落地。
Clin J Am Soc Nephrol. 2020 Jan 7;15(1):126-128. doi: 10.2215/CJN.01810219. Epub 2019 Nov 18.
6
Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.将载脂蛋白L1（APOL1）基因变异纳入肾移植：美国移植学会专家会议引发的思考
Am J Transplant. 2017 Apr;17(4):901-911. doi: 10.1111/ajt.14173. Epub 2017 Feb 2.
7
Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.载脂蛋白 L1 检测在非裔美国人中的应用：社区参与政策讨论。
Am J Nephrol. 2019;50(4):303-311. doi: 10.1159/000502675. Epub 2019 Sep 3.
8
Comparison of Postdonation Kidney Function Between Caucasian Donors and Low-risk APOL1 Genotype Living Kidney Donors of African Ancestry.白种人供体与低风险APOL1基因型非洲裔活体肾供体捐献后肾功能的比较。
Transplantation. 2018 Nov;102(11):e462-e463. doi: 10.1097/TP.0000000000002405.
9
Apolipoprotein L1 Gene Effects on Kidney Transplantation.载脂蛋白 L1 基因对肾移植的影响。
Semin Nephrol. 2017 Nov;37(6):530-537. doi: 10.1016/j.semnephrol.2017.07.006.
10
Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.检测潜在活体肾脏供者中的高危 APOL1 等位基因。
Am J Kidney Dis. 2015 Sep;66(3):396-401. doi: 10.1053/j.ajkd.2015.04.046. Epub 2015 Jun 3.
引用本文的文献
1
Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine.解码肾脏病理生理学：精准医学中基于组学的方法
J Pers Med. 2024 Dec 19;14(12):1157. doi: 10.3390/jpm14121157.
2
Attitudes Toward Use of an APOL1 Genetic Testing Chatbot in Living Kidney Donor Evaluation: A Focus Group Study.对活体肾供体评估中使用APOL1基因检测聊天机器人的态度：一项焦点小组研究。
Clin Transplant. 2024 Dec;38(12):e70026. doi: 10.1111/ctr.70026.
3
Defining Risk in APOL1-Associated Kidney Disease: The Story is Evolving!定义APOL1相关肾病的风险：故事仍在演变！
Am J Kidney Dis. 2024 Sep;84(3):388-391. doi: 10.1053/j.ajkd.2024.03.016. Epub 2024 Apr 20.
4
Development of a culturally targeted chatbot to inform living kidney donor candidates of African ancestry about APOL1 genetic testing: a mixed methods study.开发一个针对特定文化群体的聊天机器人，以告知非洲裔活体肾供体候选人关于APOL1基因检测的信息：一项混合方法研究。
J Community Genet. 2024 Apr;15(2):205-216. doi: 10.1007/s12687-024-00698-8. Epub 2024 Feb 13.
5
Evaluating ApoL1 Genetic Testing Policy Options for Transplant Centers: A Delphi Consensus Panel Project with Stakeholders.评估移植中心 ApoL1 基因检测政策方案：利益相关者德尔菲共识小组项目。
Clin J Am Soc Nephrol. 2024 Apr 1;19(4):494-502. doi: 10.2215/CJN.0000000000000397. Epub 2024 Jan 8.
6
Transplant Nephrologists' Preferences for Clinical Decision Support for APOL1 Genetic Testing of Living Kidney Donors: A Focus Group Study.移植肾脏病专家对活体肾脏供者 APOL1 基因检测的临床决策支持的偏好：一项焦点小组研究。
Kidney360. 2023 Nov 1;4(11):1610-1614. doi: 10.34067/KID.0000000000000265. Epub 2023 Oct 12.
7
Monogenic and polygenic concepts in chronic kidney disease (CKD).单基因和多基因概念在慢性肾脏病（CKD）中的应用。
J Nephrol. 2024 Jan;37(1):7-21. doi: 10.1007/s40620-023-01804-8. Epub 2023 Nov 21.
8
Implementation of a culturally competent genetic testing programme into living donor evaluation: A two-site, non-randomised, pre-post trial design.将文化能力纳入活体供者评估的基因检测项目的实施：一项两站点、非随机、前后试验设计。
BMJ Open. 2023 May 15;13(5):e067657. doi: 10.1136/bmjopen-2022-067657.
9
APOL1 and APOL1-Associated Kidney Disease: A Common Disease, an Unusual Disease Gene - Proceedings of the Henry Shavelle Professorship.载脂蛋白L1与载脂蛋白L1相关肾病：一种常见疾病，一个不寻常的致病基因——亨利·沙维尔教授任职演讲文集
Glomerular Dis. 2023 Jan 25;3(1):75-87. doi: 10.1159/000529227. eCollection 2023 Jan-Dec.
10
Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment.活体供肾移植中遗传性肾脏疾病的评估：迈向供体风险评估中的精准基因组医学
Curr Transplant Rep. 2022 Jun;9(2):127-142. doi: 10.1007/s40472-021-00340-3. Epub 2022 Mar 16.
Zotero 插件